Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,716Revenue $M16.1Net Margin (%)-691.7Altman Z-Score-2.9
Enterprise Value $M2,452EPS $-1.0Operating Margin %-114.6Piotroski F-Score4
P/E(ttm)--Beneish M-Score475Pre-tax Margin (%)-422.2Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %-29.0Quick Ratio23.9Cash flow > EarningsY
Price/Sales1035-y EBITDA Growth Rate %-38.1Current Ratio23.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-20.1Higher Current Ratio y-yY
Dividend Yield %6.8PEG--ROE % (ttm)-444.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M117ROIC % (ttm)-6.7Gross Margin Increase y-yN

Gurus Latest Trades with THRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
THRXJoel Greenblatt 2015-03-31 Buy 0.01%$10.68 - $20.2
($15.13)
$ 14.68-3%New holding52,837
THRXFirst Eagle Investment 2015-03-31 Add$10.68 - $20.2
($15.13)
$ 14.68-3%Add 5.48%1,680,910
THRXSeth Klarman 2014-09-30 Reduce-0.28%$17.53 - $30.4
($22.87)
$ 14.68-36%Reduce 2.84%19,815,983
THRXSeth Klarman 2014-06-30 Reduce-0.23%$21.154 - $30.1
($23.88)
$ 14.68-39%Reduce 1.50%20,395,056
THRXSeth Klarman 2014-03-31 Add0.42%$24.31 - $32.63
($29.32)
$ 14.68-50%Add 2.79%20,705,801
THRXSeth Klarman 2013-12-31 Add1.65%$27.19 - $32.81
($29.19)
$ 14.68-50%Add 8.83%20,144,301
THRXFirst Eagle Investment 2013-12-31 Add0.03%$27.19 - $32.81
($29.19)
$ 14.68-50%Add 23.40%1,509,404
THRXSeth Klarman 2013-09-30 Add2.3%$28.86 - $34.36
($31.06)
$ 14.68-53%Add 11.92%18,510,371
THRXSeth Klarman 2013-06-30 Add2.85%$18.15 - $33.74
($26.83)
$ 14.68-45%Add 22.02%16,538,977
THRXFirst Eagle Investment 2013-06-30 Add0.08%$18.15 - $33.74
($26.83)
$ 14.68-45%Add 139.14%1,109,620
THRXFirst Eagle Investment 2012-06-30 Add0.01%$14.11 - $19.04
($16.72)
$ 14.68-12%Add 24.23%509,710
THRXSeth Klarman 2012-03-31 Add0.22%$13.21 - $16.28
($13.91)
$ 14.686%Add 2.30%14,553,800
THRXFirst Eagle Investment 2012-03-31 Add0.01%$13.21 - $16.28
($13.91)
$ 14.686%Add 25.59%410,310
THRXJulian Robertson 2011-09-30 Sold Out -1.2512%$14.05 - $20.04
($16.74)
$ 14.68-12%Sold Out0
THRXSeth Klarman 2011-09-30 Add0.84%$14.05 - $20.04
($16.74)
$ 14.68-12%Add 9.76%14,225,961
THRXFirst Eagle Investment 2011-06-30 Reduce-0.02%$17.07 - $23.13
($20)
$ 14.68-27%Reduce 33.79%326,710
THRXDavid Swensen 2011-03-31 Sold Out -6.58%$16.91 - $20.77
($18.79)
$ 14.68-22%Sold Out0
THRXJulian Robertson 2011-03-31 Reduce-0.35%$16.91 - $20.77
($18.79)
$ 14.68-22%Reduce 20.94%211,686
THRXFirst Eagle Investment 2011-03-31 Add0.02%$16.91 - $20.77
($18.79)
$ 14.68-22%Add 51.02%493,410
THRXWilbur Ross 2011-03-31 Sold Out $16.91 - $20.77
($18.79)
$ 14.68-22%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

THRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


THRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Tyree James LDirector 2015-06-02Sell2,438$16.85-12.05view
WALTRIP WILLIAM HDirector 2015-05-27Sell16,313$16.32-9.19view
GLAXOSMITHKLINE PLC10% Owner 2015-05-11Buy85,579$1369260-100view
GLAXOSMITHKLINE PLC10% Owner 2015-03-02Buy92,674$18.06-17.94view
GLAXOSMITHKLINE PLC10% Owner 2014-11-04Buy832,456$15.36-3.52view
LEE JUNNINGSr. VP, Technical Operations 2014-08-13Sell53,424$22.5-34.13view
Shafer Bradford JSr VP, Gen. Counsel, Secretary 2014-08-12Sell28,156$22.13-33.03view
GLAXOSMITHKLINE PLC10% Owner 2014-08-11Buy172,651$22.66-34.6view
GLAXOSMITHKLINE PLC10% Owner 2014-05-09Buy317,770$26.89-44.89view
Shafer Bradford JSr VP, Gen. Counsel, Secretary 2014-03-03Sell65,806$36.73-59.65view

Press Releases about THRX :

Quarterly/Annual Reports about THRX:

News about THRX:

Articles On GuruFocus.com
Theravance to Report Second Quarter 2015 Financial Results on July 29, 2015 Jul 22 2015 
Theravance, Inc. Appoints Michael Faerm as Chief Business Officer Jul 13 2015 
main Jul 11 2015 
main Jul 01 2015 
main Jul 01 2015 
Insiders' New Buys : MAC, SPB, PDVW, HNSN, THRX, RSG, CVX May 18 2015 
Seth Klarman's Trades During Q1 2015 Apr 20 2015 
Richard Perry's Fourth-Quarter Transactions Had High Impact on Portfolio Feb 16 2015 
Seth Klarman Keeps Buying LNG, KERX, PBF And Keeps Selling THRX Dec 05 2014 
Data Published on Anoro(R) Ellipta(R) Demonstrate Improved Lung Function Compared to Tiotropium Oct 17 2014 

More From Other Websites
*** DATA NOT AVAILABLE *** Aug 04 2015
Theravance Biopharma to Present at the Wedbush PacGrow Healthcare Conference Jul 30 2015
Edited Transcript of THRX earnings conference call or presentation 29-Jul-15 9:00pm GMT Jul 30 2015
Theravance reports 2Q loss Jul 29 2015
Theravance reports 2Q loss Jul 29 2015
Theravance Inc Earnings Call scheduled for 5:00 pm ET today Jul 29 2015
THERAVANCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in... Jul 29 2015
Theravance Reports Second Quarter 2015 Financial Results Jul 29 2015
Theravance Biopharma to Report Second Quarter 2015 Financial Results on August 10, 2015 Jul 28 2015
Theravance Biopharma Announces Health Canada Approval for VIBATIV(R) (telavancin) for Treatment of... Jul 23 2015
Theravance to Report Second Quarter 2015 Financial Results on July 29, 2015 Jul 22 2015
THERAVANCE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 13 2015
Theravance, Inc. Appoints Michael Faerm as Chief Business Officer Jul 13 2015
Theravance Biopharma Announces New Employment Inducement Awards Jul 02 2015
THERAVANCE INC Files SEC form 8-K, Regulation FD Disclosure Jul 01 2015
Theravance Biopharma Announces Marketing Authorization for VIBATIV(R) (Telavancin) in Russia for... Jun 30 2015
HTML PDF Jun 26 2015
5 Biotech Stocks Poised for Breakouts Jun 05 2015
Theravance Biopharma Announces New Employment Inducement Awards Jun 02 2015
Theravance Biopharma and SciClone Pharmaceuticals Enter Into Development and Commercialization... May 27 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK